USPTO serial 98365795
BRENUS PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 25, 2025
- Examiner
- LAMONT, MIAH ROSENBERG
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BRENUS PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Clermont-Ferrand, FR
Clermont-Ferrand, FR
Clermont-Ferrand, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca, and Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Cell culture services for scientific and research purposes, for others; Chemical, biochemical, biological and bacteriological research and analysis; Development and establishment of testing specifications and procedures in the field of medicine; Medical and scientific research in the field of pharmacology; Medical research laboratory services; Medical research laboratory services in the field of oncology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research information in the field of pharmaceuticals; Providing scientific information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research and development in the field of immunotherapy; Research and development in the field of oncology; Research and development in the field of biotechnological and pharmaceutical drugs; Research and development in the field of advanced therapy drugs; Research and development in the field of pharmaceuticals; Research in the field of cell engineering technology; Scientific laboratory services; Scientific research for medical purposes in the field of immunotherapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 25, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 25, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 7, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 7, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2024 | ALIE | ASSIGNED TO LIE | — |
| Aug 28, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 20, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 20, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 20, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 14, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 19, 2024 | NWAP | NEW APPLICATION ENTERED | — |